...
首页> 外文期刊>IEEE/ACM transactions on computational biology and bioinformatics >Computational Drug Repositioning with Random Walk on a Heterogeneous Network
【24h】

Computational Drug Repositioning with Random Walk on a Heterogeneous Network

机译:异构网络上随机游走的计算药物重定位

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Drug repositioning is an efficient and promising strategy to identify new indications for existing drugs, which can improve the productivity of traditional drug discovery and development. Rapid advances in high-throughput technologies have generated various types of biomedical data over the past decades, which lay the foundations for furthering the development of computational drug repositioning approaches. Although many researches have tried to improve the repositioning accuracy by integrating information from multiple sources and different levels, it is still appealing to further investigate how to efficiently exploit valuable data for drug repositioning. In this study, we propose an efficient approach, Random Walk on a Heterogeneous Network for Drug Repositioning (RWHNDR), to prioritize candidate drugs for diseases. First, an integrated heterogeneous network is constructed by combining multiple sources including drugs, drug targets, diseases and disease genes data. Then, a random walk model is developed to capture the global information of the heterogeneous network. RWHNDR takes advantage of drug targets and disease genes data more comprehensively for drug repositioning. The experiment results show that our approach can achieve better performance, compared with other state-of-the-art approaches which prioritized candidate drugs based on multi-source data.
机译:药物重新定位是一种有效且有前途的策略,可以识别现有药物的新适应症,从而可以提高传统药物发现和开发的生产率。在过去的几十年中,高通量技术的飞速发展已经产生了各种类型的生物医学数据,这为进一步发展计算药物重新定位方法奠定了基础。尽管许多研究试图通过整合来自多个来源和不同级别的信息来提高重新定位的准确性,但仍在进一步研究如何有效地利用有价值的数据进行药物重新定位仍然很有吸引力。在这项研究中,我们提出了一种有效的方法,即在异构药物定位异构网络(RWHNDR)上进行随机游走,以对疾病的候选药物进行优先排序。首先,通过组合包括药物,药物靶标,疾病和疾病基因数据在内的多种来源来构建一个综合的异构网络。然后,开发了随机游走模型以捕获异构网络的全局信息。 RWHNDR可以更全面地利用药物靶标和疾病基因数据来进行药物重新定位。实验结果表明,与其他基于多源数据对候选药物进行优先排序的最新技术相比,我们的方法可以实现更好的性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号